The RTOG CCOP Program periodically solicits projects for applications centered on pilot studies leading to Phase II or Phase III symptom management intervention trials.
The RTOG CCOP focuses on mitigating RT-associated normal tissue toxicity, treating therapy related side-effects and improving quality of life. High priority areas for the RTOG CCOP are:
· Mucosal Protectants and Epithelial Injury;
· Palliation and Quality of Life;
· Late Effects and Survivorship.
Additional information on the application process can be found in the announcement. Announcements are broadcasted via the RTOG Broadcast List and can also be found on this web page.
RFA Issue Date:
Application Submission Due Date:
September 17, 2012
Prior RFAs Issued:
Date Issued: February 16, 2012 Awarded: April 2012
Date Issued: November 3, 2011 Awarded: January 2012
Date Issued: December 3, 2010 Awarded: January 2011
CCOP Pilot Grants Awarded
Submitting Progress Reports for Funded Projects